Tabernanthalog
Experimental, non-hallucinogenic ibogaine derivative that showed antidepressant-like effects in rodents; not studied in humans.
Pharmacology
Contents
DETAILED OVERVIEW
What is Tabernanthalog?
Tabernanthalog (TBG) is an experimental compound: a lab-designed, non-hallucinogenic version of ibogaine, the psychoactive substance of the iboga plant. It is meant to boost the brain's ability to adapt, meaning the rebuilding of connections between nerve cells. It is not approved as a medicine anywhere and is not a dietary supplement; it is only a research compound, and its legal situation is unclear.
It switches on one of the serotonin receptors, but in a way that starts a nerve-growth pathway instead of hallucinations. In rodents, antidepressant-like effects, less alcohol- and drug-seeking behavior and repair of stress-damaged neural circuits were seen. It has never been tested in humans, so its safety is unknown. It was designed to avoid ibogaine's dangerous heart-rhythm problem (QT prolongation), but this has not been confirmed in people. Its safety in pregnancy and breastfeeding has not been established, and in theory it is risky in heart disease and alongside drugs that act on the serotonin system.
Mechanism
Partial serotonin 2A receptor activator; boosts nerve adaptability
Evidence
Preclinical only (cell + rodent, no human data)
Legal status
Unapproved research compound
No anecdote collected yet.
Receptor profile
- 5-HT2A receptorStrong
- TrkB / BDNF signalingModerate
- hERG channel (low affinity, reduced cardiac-rhythm risk)Weak
Safety
Side effects, stop signs, contraindications
Side effects · 5
- No human safety data: only cell and animal (rodent) studies exist; the compound has never been tested in humans
- Unknown long-term safety and incomplete toxicity profile in humans
- As a 5-HT2A agonist it may theoretically cause transient anxiety, blood-pressure rise or headache
- Designed to reduce the cardiac-rhythm (hERG/QT) risk seen with ibogaine, but this is unconfirmed in humans
- Nicotinic (α7, α9α10) receptor inhibition from animal data: human relevance unknown
Contraindications · 4
- Pregnancy and breastfeeding: safety not established, avoid
- Cardiovascular disease, arrhythmia or prolonged QT: caution due to 5-HT2A/hERG activity
- Serotonergic drugs (SSRIs, MAO inhibitors, triptans): theoretical serotonin-syndrome risk
- Not an approved medicine or dietary supplement; experimental research compound, not recommended without clinical supervision
Related Nootropics
Same therapeutic category
Studies
Related research and clinical findings
A non-hallucinogenic psychedelic analogue with therapeutic potential
Cameron LP, Tombari RJ, Lu J, Pell AJ, Hurley ZQ, Ehinger Y, et al.
An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress
Lu J, Tjia M, Mullen B, Cao B, Lukasiewicz K, Shah-Morales S, et al.
Engineering Safer Psychedelics for Treating Addiction
Cameron LP, Patel SD, Vargas MV, Barragan EV, Saeger HN, Warren HT, et al.
Tabernanthalog Reduces Motivation for Heroin and Alcohol in a Polydrug Use Model
Heinsbroek JA, Giannotti G, Bonneau N, Cameron LP, Olson DE, Ford CP, et al.
Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABAA receptor and CaV2.2 channel
Arias HR, Tae HS, Micheli L, Yousuf A, Ghelardini C, Adams DJ, et al.
Non-hallucinogenic compounds derived from iboga alkaloids alleviate neuropathic and visceral pain in mice through a mechanism involving 5-HT2A receptor activation
Di Cesare Mannelli L, Tenci B, Micheli L, Arias HR, Ghelardini C, et al.
FAQ
FAQ
Tabernanthalog is a lab-designed compound built from the psychoactive ingredient of the iboga plant (ibogaine), engineered to skip the hallucinogenic effects. In animal studies it eased depression-like symptoms, reduced alcohol- and drug-seeking behavior, and helped restore stress-damaged neural connections. It is still purely an experimental compound with essentially no human data yet.
Telegram
Have a question about Tabernanthalog?
Reach out to us on Telegram for a personalized stack. We'll be happy to help.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
Structure & chemistry
The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.